Stockscreener 앱 받기
9.44
5.83%
0.52
시장 영업 전:
9.43
-0.010
-0.11%
전일 마감가:
$8.92
열려 있는:
$8.7823
하루 거래량:
2,933
Relative Volume:
0.14
시가총액:
$14.50M
수익:
$630.00K
순이익/손실:
$5.72M
주가수익비율:
-27.64
EPS:
-0.3415
순현금흐름:
$-6.75M
1주 성능:
+2.61%
1개월 성능:
+21.80%
6개월 성능:
+37.41%
1년 성능:
-8.70%
1일 변동 폭
$8.7823
$9.51
1주일 범위
$8.68
$9.592
52주 변동 폭
$6.51
$12.05
Addex Therapeutics Ltd Adr Stock (ADXN) Company Profile
ADXN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ADXN
Addex Therapeutics Ltd Adr
|
9.44 | 8.27M | 630.00K | 5.72M | -6.75M | -0.3415 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Addex Therapeutics Ltd Adr Stock (ADXN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-07-31 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
Addex Therapeutics Ltd Adr 주식(ADXN)의 최신 뉴스
Addex Therapeutics Earnings Call: Strategic Gains Amid Challenges - TipRanks
Addex Therapeutics Ltd. Sponsored ADR (NASDAQ:ADXN) Sees Significant Increase in Short Interest - Defense World
Addex Therapeutics Reports Significant Loss Amid Financial Challenges - TipRanks
Addex Therapeutics H1 2025 Earnings Call Transcript - MarketBeat
Will V.F. Corporation (VFP) stock see valuation expansionExit Point & AI Driven Stock Movement Reports - newser.com
Addex Therapeutics (NASDAQ:ADXN) Shares Down 6.5% – What’s Next? - Defense World
Lion Group (NASDAQ:LGHL) Stock Price Down 4.3% – Here’s Why - Defense World
Are Medical Stocks Lagging ADMA Biologics (ADMA) This Year? - MSN
Can trapped investors hope for a rebound in Vine Hill Capital Investment Corp.Quarterly Profit Report & Pattern Based Trade Signal System - newser.com
Applying sector rotation models to Quipt Home Medical Corp.Portfolio Profit Report & Expert Verified Stock Movement Alerts - newser.com
Is This The Best Time To Buy iSpecimen Inc (NASDAQ: ISPC) Stock? - stocksregister.com
How to read the order book for Addex Therapeutics Ltd Depositary ReceiptInsider Buying & Long Hold Capital Preservation Plans - Newser
What earnings revisions data tells us about Core Scientific Inc.Earnings Summary Report & Daily Stock Momentum Reports - Newser
Strategies to average down on Addex Therapeutics Ltd Depositary ReceiptPortfolio Return Report & Weekly High Conviction Trade Ideas - Newser
Should you hold or exit SONY nowExit Point & Intraday High Probability Setup Alerts - Newser
Can trapped investors hope for a rebound in Titan Machinery Inc.Earnings Recap Summary & AI Enhanced Execution Alerts - Newser
Real time pattern detection on Grayscale Bitcoin Mini Trust stock3-Day Market Movement Forecast Analysis - Newser
Can GSK plc ADRhedged hit a new high this monthSmart Entry Signals for Active Traders - Newser
Combining price and volume data for Flux Power Holdings Inc.Free AI Driven Stock Trend Forecast - Newser
Most active stocks: US stocks with the highest trading volume today - Yahoo.co
Addex Therapeutics (NASDAQ:ADXN) Stock Price Down 4.5% – Here’s Why - Defense World
ADR Ratio Change - Yahoo
Addex Therapeutics Reports Q1 2025 Financial Results - TipRanks
Earnings call transcript: Addex Therapeutics highlights Q1 2025 progress - Investing.com
Addex Therapeutics to Release Q1 2025 Financial Results and Host Conference Call on June 19, 2025 - GlobeNewswire Inc.
European Equities See Growth In US ADR Market - Finimize
Addex Raises $10.0 Million In Equity Financing - Barchart.com
Addex Therapeutics Earnings Call: Strategic Gains Amid Financial Challenges - TipRanks
Addex Therapeutics Reports Strong 2024 Financial Turnaround - TipRanks
META_TITLE_SECTORS - Yahoo Finance
Are Medical Stocks Lagging Addex Therapeutics (ADXN) This Year? - Nasdaq
Akebia Therapeutics (AKBA) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance
Are Medical Stocks Lagging Boston Scientific (BSX) This Year? - Yahoo Finance
What Makes Addex Therapeutics (ADXN) a New Buy Stock - Nasdaq
Addex Stock Soars on Crucial Update From Indivior Research Deal - Zacks Investment Research
Is Boston Scientific (BSX) Stock Outpacing Its Medical Peers This Year? - Nasdaq
Earnings call: Addex Therapeutics reports on collaborations and financials - Investing.com
Esperion Therapeutics (ESPR) Reports Q3 Loss, Tops Revenue Estimates - Nasdaq
Addex Therapeutics earnings matched, revenue topped estimates - Investing.com India
Where to Find Earnings Call Transcripts - MarketBeat
Addex Therapeutics (ADXN) Stock Rallied 62.1% on Phase 2 Study - AskTraders.com
Addex Therapeutics Ltd. Sponsored ADR (ADXN) Reports Q3 Loss, Tops Revenue Estimates - Nasdaq
Le 1001 azioni che si sono schiantate sul mercato azionario USA - Scenari Economici
Addex (ADXN) Terminates Parkinson's-Related Dyskinesia Study - Nasdaq
Addex To Present At The H.C. Wainwright BIOCONNECT Virtual Conference - Barchart.com
Addex Reports Q3 2021 Financial Results And Provides Corporate Update - Barchart.com
Addex Therapeutics (ADXN) Stock Price, News & Analysis - MarketBeat
The Daily Biotech Pulse: AbbVie, Allergan Agree On Divestments, Obalon Stops Obesity Balloon Sale, COVID-19 Updates - Yahoo Finance
ADXN Stock Price and Chart — SIX:ADXN - TradingView
Addex Therapeutics Ltd Adr (ADXN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
5.74%
자본화:
|
볼륨(24시간):